Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
批准号:
7738174
负责人:
Sokol Todi
金额:
$8.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-06-30
关键词:
AffectAlzheimer&aposs DiseaseAmericanAnimalsBehavioralBinding SitesBiochemistryBiological ModelsBiologyBrainCatalytic DomainCell modelCell physiologyCellsCellular StressCellular biologyCessation of lifeDeubiquitinating EnzymeDeubiquitinationDevelopmentDiseaseDisease modelDrosophila genusEnzymesEyeFamilyFoundationsFutureGeneticGraduate EducationHealthHumanHuman GenomeHuntington DiseaseImpairmentIn VitroInvestigationKnowledgeLaboratoriesLinkLysineMJD1 proteinMachado-Joseph DiseaseManuscriptsMentorsMentorshipMichiganModelingModificationMutateMutationNerve DegenerationNervous system structureNeurodegenerative DisordersNeuronsNeurosciencesParkinson DiseasePathologyPathway interactionsPhasePhysiologicalPlayPositioning AttributePost-Translational Protein ProcessingPreparationPrincipal InvestigatorProcessProtein BiochemistryProteinsQuality ControlRegulationReportingResearchRoleScientistSiteSpinocerebellar AtaxiasStressStudentsSystemTechniquesTissuesTrainingUbiquitinUbiquitinationWorkage relatedbaseenzyme activityflyin vivoinsightmeetingsmouse modelneurotoxicoffspringpolyglutamineprotein degradationprotein misfoldingpublic health relevanceresponseskillsubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Neurodegeneration is closely linked to perturbations in protein quality control (PQC). Ubiquitin pathways are central to PQC through their role in protein degradation. Here, I will investigate how deubiquitinatng enzymes (DUBs), integral components of ubiquitin pathways, are regulated by ubiquitination and how ubiquitination in turn affects their roles in PQC. These studies focus initially on a unique DUB and polyglutamine disease protein, ataxin-3 (ATS), and later will be extended to other brain-expressed DUBs. Mentored Phase (Dr. Henry Paulson; Univ. of Michigan): ATS is a deubiquitinating enzyme that functions in PQC. Mutations in ATS cause Spinocerebellar Ataxia Type S. I have collected evidence that ATS is ubiquitinated and its ubiquitinaion increases in proteotoxic stress. Importantly, ubiquitination directly enhances ATS activity. Here, I will determine where ATS is ubiquitinated, how ubiquitination activates it, and examine changes in ATS ubiquitination in neurodegeneration. As ubiquitination may regulate DUBs generally, I will also study ubiquitination of other brain-expressed DUBs (JosDI & 2, USP25, 28 & S7), strong contenders for this type of regulation. Together with training in neurodegeneration and biochemistry, student mentorship, presentation of my work at various meetings, and manuscript preparation, these studies will prepare me for an independent academic position. Independent Phase: Catalytically active ATS is neuroprotective in fly models of neurodegeneration. I will generate Drosophila lines expressing wild type or non-ubiquitinatable forms of ATS throughout the nervous system or in the eye. Through structural, behavioral and physiological studies I will examine whether ATS ubiquitination is important to its neuroprotective role in intact animals. I will also extend findings from the Mentored Phase to determine if ubiquitination of other DUBs regulates their activity and their relation to PQC. Indeed, very little is known about DUB function and regulation in neurons. Together with continued development of my knowledge and skills as an independent scientist and mentor, this research will provide strong foundations for a lab that studies a family of enzymes that is important to all ubiquitin pathways. PUBLIC HEALTH RELEVANCE: Age-dependent neurodegeneration affects millions of Americans. Here, I propose to investigate mechanisms important in protecting neurons against toxic proteinaceous agents that accumulate in the brain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise-dependent mechanisms of protection in polyglutamine degeneration
-
批准号:10188094
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2021
-
负责人:Sokol Todi
-
依托单位:
Unique ubiquitin processes in misfolded protein diseases of the nervous system
-
批准号:10284055
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2021
-
负责人:Sokol Todi
-
依托单位:
Protection against Alzheimer's Disease proteins by novel ubiquitin processes
-
批准号:10283294
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:10115135
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:10369021
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9811467
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9018062
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:8667610
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9234079
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:8394928
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:8203082
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:8206841
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位: